👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Saba capital's Boaz Weinstein buys $537,796 in BlackRock innovation

Published 25/11/2024, 23:52
BIGZ
-

Boaz Weinstein, a ten percent owner through Saba Capital Management, L.P., has increased his stake in BlackRock (NYSE:BLK) Innovation & Growth Term Trust (NYSE:BIGZ) with a recent purchase of 68,422 shares. The transaction, valued at approximately $537,796, was executed at a price of $7.86 per share. This acquisition boosts Weinstein's total holdings to 57,860,159 shares. The transaction was reported in an SEC filing dated November 25, 2024.

InvestingPro Insights

Boaz Weinstein's recent investment in BlackRock Innovation & Growth Term Trust (NYSE:BIGZ) aligns with several key metrics highlighted by InvestingPro. The trust's attractive dividend yield of 13.0% as of the last ex-dividend date on November 15, 2024, stands out as a significant factor that may have influenced Weinstein's decision to increase his stake. This high yield is consistent with one of the InvestingPro Tips, which notes that BIGZ "pays a significant dividend to shareholders."

The trust's current market capitalization of $1.75 billion and a P/E ratio of 7.87 suggest a potentially undervalued position, which could be appealing to value-oriented investors like Weinstein. Additionally, BIGZ has shown strong price performance, with a year-to-date total return of 20.17% and a one-year total return of 22.39%, indicating positive momentum that may have caught the attention of the Saba Capital Management founder.

It's worth noting that BIGZ is trading near its 52-week high, with its current price at 96.61% of the peak. This information, combined with the InvestingPro Tip that the trust is "trading near 52-week high," suggests that Weinstein's purchase comes at a time of relative strength for the fund.

Investors considering following Weinstein's move might be interested to know that InvestingPro offers additional insights, with 3 more tips available for BIGZ. These could provide further context for the trust's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.